The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Psoriatic Arthritis Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global Psoriatic Arthritis Therapeutics market size is expected to reach US$ 11750 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Psoriatic Arthritis Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics and Research Labs,, are propelling Psoriatic Arthritis Therapeutics market. Nonsteroidal Anti-Inflammatory Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Disease-Modifying Antirheumatic Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psoriatic Arthritis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psoriatic Arthritis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psoriatic Arthritis Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psoriatic Arthritis Therapeutics covered in this report include Pfizer, Bayer, Novartis, Abbott Laboratories, Sanofi, Bristol-Myers Squibb, Janssen Biotech, Amgen and UCB, etc.
The global Psoriatic Arthritis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Bayer
Novartis
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Janssen Biotech
Amgen
UCB
AbbVie
Global Psoriatic Arthritis Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psoriatic Arthritis Therapeutics market, Segment by Type:
Nonsteroidal Anti-Inflammatory Drug
Disease-Modifying Antirheumatic Drug
Biologic Drug
Enzyme Inhibitor
Global Psoriatic Arthritis Therapeutics market, by Application
Hospitals
Clinics
Research Labs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Psoriatic Arthritis Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global Psoriatic Arthritis Therapeutics market size is expected to reach US$ 11750 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Psoriatic Arthritis Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics and Research Labs,, are propelling Psoriatic Arthritis Therapeutics market. Nonsteroidal Anti-Inflammatory Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Disease-Modifying Antirheumatic Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psoriatic Arthritis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psoriatic Arthritis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psoriatic Arthritis Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psoriatic Arthritis Therapeutics covered in this report include Pfizer, Bayer, Novartis, Abbott Laboratories, Sanofi, Bristol-Myers Squibb, Janssen Biotech, Amgen and UCB, etc.
The global Psoriatic Arthritis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Bayer
Novartis
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Janssen Biotech
Amgen
UCB
AbbVie
Global Psoriatic Arthritis Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psoriatic Arthritis Therapeutics market, Segment by Type:
Nonsteroidal Anti-Inflammatory Drug
Disease-Modifying Antirheumatic Drug
Biologic Drug
Enzyme Inhibitor
Global Psoriatic Arthritis Therapeutics market, by Application
Hospitals
Clinics
Research Labs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Psoriatic Arthritis Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Psoriatic Arthritis Therapeutics
1.1 Psoriatic Arthritis Therapeutics Market Overview
1.1.1 Psoriatic Arthritis Therapeutics Product Scope
1.1.2 Psoriatic Arthritis Therapeutics Market Status and Outlook
1.2 Global Psoriatic Arthritis Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Psoriatic Arthritis Therapeutics Market Size by Region (2018-2029)
1.4 Global Psoriatic Arthritis Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Psoriatic Arthritis Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Psoriatic Arthritis Therapeutics Market Size (2018-2029)
1.6.1 North America Psoriatic Arthritis Therapeutics Market Size (2018-2029)
1.6.2 Europe Psoriatic Arthritis Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size (2018-2029)
1.6.4 Latin America Psoriatic Arthritis Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size (2018-2029)
2 Psoriatic Arthritis Therapeutics Market by Type
2.1 Introduction
2.1.1 Nonsteroidal Anti-Inflammatory Drug
2.1.2 Disease-Modifying Antirheumatic Drug
2.1.3 Biologic Drug
2.1.4 Enzyme Inhibitor
2.2 Global Psoriatic Arthritis Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Psoriatic Arthritis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Psoriatic Arthritis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Psoriatic Arthritis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Psoriatic Arthritis Therapeutics Revenue Breakdown by Type (2018-2029)
3 Psoriatic Arthritis Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Research Labs
3.2 Global Psoriatic Arthritis Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Psoriatic Arthritis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Psoriatic Arthritis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Psoriatic Arthritis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Psoriatic Arthritis Therapeutics Revenue Breakdown by Application (2018-2029)
4 Psoriatic Arthritis Therapeutics Competition Analysis by Players
4.1 Global Psoriatic Arthritis Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2022)
4.3 Date of Key Players Enter into Psoriatic Arthritis Therapeutics Market
4.4 Global Top Players Psoriatic Arthritis Therapeutics Headquarters and Area Served
4.5 Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Psoriatic Arthritis Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.1.4 Pfizer Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.2.4 Bayer Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.3.4 Novartis Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.4.4 Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.5.4 Sanofi Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Bristol-Myers Squibb
5.6.1 Bristol-Myers Squibb Profile
5.6.2 Bristol-Myers Squibb Main Business
5.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Recent Developments
5.7 Janssen Biotech
5.7.1 Janssen Biotech Profile
5.7.2 Janssen Biotech Main Business
5.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.7.4 Janssen Biotech Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Janssen Biotech Recent Developments
5.8 Amgen
5.8.1 Amgen Profile
5.8.2 Amgen Main Business
5.8.3 Amgen Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.8.4 Amgen Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Amgen Recent Developments
5.9 UCB
5.9.1 UCB Profile
5.9.2 UCB Main Business
5.9.3 UCB Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.9.4 UCB Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 UCB Recent Developments
5.10 AbbVie
5.10.1 AbbVie Profile
5.10.2 AbbVie Main Business
5.10.3 AbbVie Psoriatic Arthritis Therapeutics Products, Services and Solutions
5.10.4 AbbVie Psoriatic Arthritis Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 AbbVie Recent Developments
6 North America
6.1 North America Psoriatic Arthritis Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Psoriatic Arthritis Therapeutics Market Dynamics
11.1 Psoriatic Arthritis Therapeutics Industry Trends
11.2 Psoriatic Arthritis Therapeutics Market Drivers
11.3 Psoriatic Arthritis Therapeutics Market Challenges
11.4 Psoriatic Arthritis Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
